noscript

News and Announcements

SUDA Update: Funding for Second Phase III Study of ArTiMist™, BIO-Europe Spring International Partnering Conference & More

  • Published April 19, 2016 10:58AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

19th Apriul 2016, ASX Announcement

SUDA LTD (ASX: SUD), a leader in oro-mucosal drug delivery, today announces an update on its business development activities. The Company is in advanced negotiations with multiple pharmaceutical companies regarding licensing its first-in-class oral sprays in a variety of countries. Subject to successful contact negotiations, SUDA aims to finalise agreements within the next few months. Discussions with philanthropic groups and other providers on non-dilutive funding for a second Phase III study of ArTiMist™ in paediatric malaria are also progressing.

The business development team attended the BIO-Europe Spring international partnering conference, which was held in Stockholm, Sweden, on 4-6 April 2016. The team has one-to-one meetings with over 30 pharmaceutical companies.

To view the full article please click on the button below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now